Elsevier

The Lancet

Volume 350, Issue 9082, 27 September 1997, Pages 900-901
The Lancet

Commentary
Simplified vs complex adjuvant chemotherapy schedule for osteosarcoma

https://doi.org/10.1016/S0140-6736(05)63262-XGet rights and content

References (1)

  • G Rosen et al.

    Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

    Cancer

    (1982)

Cited by (12)

  • Multifunctional microcapsules: A theranostic agent for US/MR/PAT multi-modality imaging and synergistic chemo-photothermal osteosarcoma therapy

    2022, Bioactive Materials
    Citation Excerpt :

    Osteosarcoma is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin and triggers osteoblastic differentiation and malignant osteoid [1,2]. In general, therapeutic strategies comprise the aggressive multimodal therapy including preoperative (neoadjuvant) chemotherapy followed by surgical removal of all detectable disease, and postoperative (adjuvant) chemotherapy [3–5]. Currently, most active chemotherapeutic agents for osteosarcoma are a combination of high-dose methotrexate, doxorubicin, and cisplatin with the use of IFN-α or the recent immunomodulatory mifamurtide during adjuvant chemotherapy [6,7].

  • Carbon dot/WS<inf>2</inf> heterojunctions for NIR-II enhanced photothermal therapy of osteosarcoma and bone regeneration

    2020, Chemical Engineering Journal
    Citation Excerpt :

    Osteosarcoma is an aggressive malignant neoplasm that is most prevalent in teenagers and young adults [1,2]. In the clinic, surgical resection is commonly used to treat osteosarcoma [3–5]. However, incomplete bone-tumor cell elimination and the formation of bone defects seriously hinder the clinic application of surgical intervention [6,7].

  • Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma

    2015, Acta Biomaterialia
    Citation Excerpt :

    Osteosarcoma is the most common type of primary bone tumors and the second high cause of cancer-related deaths in children and young adults [1].

View all citing articles on Scopus
View full text